PMID- 32507344 OWN - NLM STAT- MEDLINE DCOM- 20210216 LR - 20210216 IS - 0929-6646 (Print) IS - 0929-6646 (Linking) VI - 120 IP - 1 Pt 1 DP - 2021 Jan TI - Impact of inhaled corticosteroids on the neurodevelopmental outcomes in chronically ventilated extremely low birth weight preterm infants. PG - 275-280 LID - S0929-6646(20)30205-9 [pii] LID - 10.1016/j.jfma.2020.05.015 [doi] AB - BACKGROUND: Few studies have assessed the long-term impact of inhaled corticosteroids (ICS) in preterm infants. This study evaluated the neurodevelopmental outcomes of chronically ventilated extremely low birth weight (ELBW) preterm infants exposed to ICS. METHODS: The medical records of ELBW preterm infants admitted to two tertiary-level neonatal intensive care units from 2008 to 2014 were reviewed. Infants intubated for more than 28 days were included. The neurodevelopmental outcomes were compared at 24 months corrected age, between those with ICS exposure (inhaled group, IH) and those without it (non-inhaled group, NIH), by using the Bayley-Scale-of-Infant-and-Toddler Development-III (BSID-III). RESULTS: Out of the 115 infants included, 64 had an ICS exposure. The incidence of the morbidities at the time of discharge, was comparable between the two groups, except for the duration of oxygen and mechanical ventilation dependence (IH 124.8 +/- 40.3 days vs. NIH: 101.0 +/- 28.6 days, p < 0.001 and IH 60.0 +/- 25.8 days vs. NIH: 42.3 +/- 14.2 days, p < 0.001, respectively). Multiple logistic regression analysis at 24 months corrected age revealed no significant differences in the BSID-III scores and in the incidence of cerebral palsy and neurodevelopmental impairment. CONCLUSION: The late ICS exposure was not associated with neurodevelopmental impairment at 24 months corrected age in chronically ventilated ELBW infants; however, it did not reduce the duration of their dependence on oxygen and mechanical ventilation. CI - Copyright (c) 2020 Formosan Medical Association. Published by Elsevier B.V. All rights reserved. FAU - Tiong, Ngiik-Ping AU - Tiong NP AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan. FAU - Peng, Chun-Chih AU - Peng CC AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan. FAU - Hsin-Ju Ko, Mary AU - Hsin-Ju Ko M AD - Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan. FAU - Tseng, Kai-Ti AU - Tseng KT AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan. FAU - Chang, Jui-Hsing AU - Chang JH AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan. FAU - Hsu, Chyong-Hsin AU - Hsu CH AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan. FAU - Sung, Yi-Hsiang AU - Sung YH AD - Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan. FAU - Chang, Hung-Yang AU - Chang HY AD - Department of Neonatology, MacKay Children's Hospital, Taipei City, Taiwan; Department of Medicine, Mackay Medical College, New Taipei City, Taiwan; Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu City, Taiwan. Electronic address: drhychang@gmail.com. LA - eng PT - Journal Article DEP - 20200603 PL - Singapore TA - J Formos Med Assoc JT - Journal of the Formosan Medical Association = Taiwan yi zhi JID - 9214933 RN - 0 (Adrenal Cortex Hormones) RN - 0 (Glucocorticoids) SB - IM MH - Adrenal Cortex Hormones/adverse effects MH - Glucocorticoids MH - Humans MH - Infant MH - *Infant, Extremely Low Birth Weight MH - Infant, Newborn MH - Intensive Care Units, Neonatal OTO - NOTNLM OT - Extremely low birth weight infants OT - Inhaled corticosteroid OT - Neurodevelopment impairment COIS- Declaration of Competing Interest The authors have no conflicts of interest relevant to this article. EDAT- 2020/06/09 06:00 MHDA- 2021/02/17 06:00 CRDT- 2020/06/09 06:00 PHST- 2020/01/05 00:00 [received] PHST- 2020/05/13 00:00 [revised] PHST- 2020/05/14 00:00 [accepted] PHST- 2020/06/09 06:00 [pubmed] PHST- 2021/02/17 06:00 [medline] PHST- 2020/06/09 06:00 [entrez] AID - S0929-6646(20)30205-9 [pii] AID - 10.1016/j.jfma.2020.05.015 [doi] PST - ppublish SO - J Formos Med Assoc. 2021 Jan;120(1 Pt 1):275-280. doi: 10.1016/j.jfma.2020.05.015. Epub 2020 Jun 3.